180 Degree Capital Investor

They participate in venture capital syndicates in most of their investments, alongside top-tier venture capital firms as well as strategic (corporate) investors. Increasingly, Harris & Harris Group is a lead investor. They believe in the classical early stage venture capital model and disciplines and that most technology-based start-ups can use all the help they can get from the diversified experiences, Rolodexes®, complimentary business networks, technical expertise, up-to-date customer connections and financial resources that a syndicate of professional venture capital investors can provide.
Technology: Drug Discovery
Industry: Neurotech
Headquarters: United States
Founded Date: 1983
Employees Number: 10-Jan
Funding Status: N/A
Investor Type: Venture Capital
Investment Stage: Debt, Early Stage Venture, Late Stage Venture, Post-Ipo, Seed
Number Of Exits: 19

Visit Website
Register and Claim Ownership